Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04372433
Title IO-202 as Monotherapy and IO-202 Plus Azacitidine +/- Venetoclax in Patients in AML and CMML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Immune-Onc Therapeutics Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.